Author： Barnes G.L. Lund J.S. Mitchell S.V. De Bruyn L. Piggford L. Smith A.L. Furmedge J. Masendycz P.J. Bugg H.C. Bogdanovic-Sakran N. Carlin J.B. Bishop R.F.
Publisher： Elsevier
ISSN： 0264-410X
Source： Vaccine, Vol.20, Iss.23, 2002-07, pp. : 2950-2956
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
By Nitayaphan S. Khamboonruang C. Sirisophana N. Morgan P. Chiu J. Duliege A.-M. Chuenchitra C. Supapongse T. Rungruengthanakit K. deSouza M. Mascola J.R. Boggio K. Ratto-Kim S. Markowitz L.E. Birx D. Suriyanon V. McNeil J.G. Brown A.E. Michael R.A.
Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. :
Access to resources
Recommend
The current status of the rotavirus vaccine
Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. :
By Lanata C.F. Black R.E. Flores J. Lazo F. Butron B. Linares A. Huapaya A. Ventura G. Gil A. Kapikian A.Z.
Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. :